+ All Categories
Home > Documents > 1 The management of adverse effects in tuberculosis treatment Dr. Özlen Tümer Süreyyapaşa Chest...

1 The management of adverse effects in tuberculosis treatment Dr. Özlen Tümer Süreyyapaşa Chest...

Date post: 12-Jan-2016
Category:
Upload: maurice-patrick
View: 212 times
Download: 0 times
Share this document with a friend
49
1 The management of The management of adverse effects in adverse effects in tuberculosis treatment tuberculosis treatment Dr. Özlen Tümer Süreyyapaşa Chest Diseases and Thoracic Surgery Teaching and Research Hospital 13th Annual Congress of Turkish Thoracic Society- İstanbul 2010
Transcript
Page 1: 1 The management of adverse effects in tuberculosis treatment Dr. Özlen Tümer Süreyyapaşa Chest Diseases and Thoracic Surgery Teaching and Research Hospital.

1

The management of adverse The management of adverse effects in tuberculosis effects in tuberculosis

treatmenttreatmentDr. Özlen Tümer

Süreyyapaşa Chest Diseases and Thoracic Surgery Teaching and

Research Hospital

13th Annual Congress of Turkish Thoracic Society-

İstanbul 2010

Page 2: 1 The management of adverse effects in tuberculosis treatment Dr. Özlen Tümer Süreyyapaşa Chest Diseases and Thoracic Surgery Teaching and Research Hospital.

2

• Tuberculosis drugs are administered in combination, therefore it is difficult to determine which drug is toxic.

• In addition there can be adverse effects due to the combination therapy.

• Management of adverse effects :If drugs are not administered properly resistance to drugs can occur.If drugs are not stopped in time the consequences can be life threatening.

Page 3: 1 The management of adverse effects in tuberculosis treatment Dr. Özlen Tümer Süreyyapaşa Chest Diseases and Thoracic Surgery Teaching and Research Hospital.

3

Risk factors for side effects• Advanced age• Malnutrition• Pregnancy,nursing• Alcolism• Liver failure• Chronic renal failure• HIV infection

• Disseminated TB• Atopy• Anemia• D. Mellitus• İnterrupted TB

therapy• Familiy history• Additional drug use

Page 4: 1 The management of adverse effects in tuberculosis treatment Dr. Özlen Tümer Süreyyapaşa Chest Diseases and Thoracic Surgery Teaching and Research Hospital.

4

Speech outline

Characteristics of drugs used in TB treatment

The side-effects of TB drugsManagement of minor adverse effectsManagement of major adverse effectsDrug interactions

Page 5: 1 The management of adverse effects in tuberculosis treatment Dr. Özlen Tümer Süreyyapaşa Chest Diseases and Thoracic Surgery Teaching and Research Hospital.

5

Characteristics of drugs used in TB treatment

The side-effects of TB drugsManagement of minor adverse effectsManagement of major adverse effectsDrug interactions

Page 6: 1 The management of adverse effects in tuberculosis treatment Dr. Özlen Tümer Süreyyapaşa Chest Diseases and Thoracic Surgery Teaching and Research Hospital.

6

groups drugs

1. First line drugs

Isoniazid, Rifampicin, Pirazinamid, Ethambutol

Second line drugs

2.Injectable drugs

Streptomycine, Amikacin, Kanamycin, Capreomycin

3.Fluoroquinolone Ofloxacin, Levofloxacin, Moxifloxacin

4.Other second line drugs

Prothionamide/Ethionamide, PAS, Cycloserine,Terizidon

5.Drugs with unclear role in Tx

Linezolid, Clofazimin, Clavulanat, Thioasetazon, imipenem/cilastatin, high dose INH, Clarithromycine

Page 7: 1 The management of adverse effects in tuberculosis treatment Dr. Özlen Tümer Süreyyapaşa Chest Diseases and Thoracic Surgery Teaching and Research Hospital.

7

Daily dose

(mg/kg/day)

drugs adult child

Max.daily dose

(mg/day)

Isoniazid 5 5-10 300

Rifampicin 10 10-15 600

Pyrazinamide 25 20-40 2000

Morfozinamide 40-50 40-60 3000

Streptomycin 15 20-30 1000

Ethambutol 15-20 15-25 1500

Page 8: 1 The management of adverse effects in tuberculosis treatment Dr. Özlen Tümer Süreyyapaşa Chest Diseases and Thoracic Surgery Teaching and Research Hospital.

8

Isoniazid (H)

• H was synthesized in 1912, and was rediscovered for TB treatment since 1952.

• It is taken orally, is cheap and good tolerable.• It inhibits the mycolic acid synthesis of the cell

wall.• After taken on empty stomach high serum

concentrations are achieved in 1-2 hours. It penetrates into cerebrospinal fluid.

Page 9: 1 The management of adverse effects in tuberculosis treatment Dr. Özlen Tümer Süreyyapaşa Chest Diseases and Thoracic Surgery Teaching and Research Hospital.

9

Isoniazid

• H is used for preventive therapy.

• The elimination of H is determined by the acetylator status of the patient. Genetically there are slow and rapid inactivators.

• H is metabolized in liver and excreted in urine

Page 10: 1 The management of adverse effects in tuberculosis treatment Dr. Özlen Tümer Süreyyapaşa Chest Diseases and Thoracic Surgery Teaching and Research Hospital.

10

Side effects of Isoniazid

• Hepatotoxicity: Risk is highest in the first 2 months of treatment. It is very rare under age 20. Daily alcohol consumption increases the risk of hepatotoxicity.If AST level is 5 times more than the upper limit of normal drugs are stopped.

• Peripheral neuropathy: Daily dosage up to 300 mg does not cause neuropaty . Preventive treatment with small dosages ( max. 10-15 mg) of pyridoxine is recommended.

Pregnancy,alcoholism, advanced age, seizures, uremia and diabetes are risk factors and indicate for preventive therapy.

Page 11: 1 The management of adverse effects in tuberculosis treatment Dr. Özlen Tümer Süreyyapaşa Chest Diseases and Thoracic Surgery Teaching and Research Hospital.

11

Side effects of Isoniazid• Seizures, hallucinosis, psychosis, optic

neuropathy,• Hypersensitivity reactions: Drug fever,

asthma, dermatitis, Stevens Johnson syndrome, hematologic disorders (hemolytic anemia,agranulocytosis etc.), vasculitis

• Lupus like syndrome, alopecia,monoamine poisoning

Page 12: 1 The management of adverse effects in tuberculosis treatment Dr. Özlen Tümer Süreyyapaşa Chest Diseases and Thoracic Surgery Teaching and Research Hospital.

12

Rifampicin(R)

• R is a semisynthetic, bactericidal drug used since 1966 clinically. R inhibits the synthesis of mRNA by binding to the RNA polymerase.

• After oral intake on empty stomach its absorption is rapid and excellent. R penetrates all body fluids well.

• R is metabolized in liver , excreted in bile and urine. • Its metabolites color urine, tears, sweat (red).)Patients

using contact lenses should be told.

Page 13: 1 The management of adverse effects in tuberculosis treatment Dr. Özlen Tümer Süreyyapaşa Chest Diseases and Thoracic Surgery Teaching and Research Hospital.

13

Side effects of rifampicinSide effects of rifampicin

• Mild elevation of serum bilirubin and liver enzymes in the first week of treatment

• Hepatotoxicity• Flu-like syndrome: Symptoms like malaise, arthralgia,

fever. It occurs when higher doses are implemented.• Pruritus and drug fever• Hypersensitivity reactions: Acute renal failure,

thrombocytopenic purpura, hemolytic anemia, anaphylactic shock,

• Toxic epidermal necrosis, pseudomembranous colitis, amenorrhea, myopathy

Page 14: 1 The management of adverse effects in tuberculosis treatment Dr. Özlen Tümer Süreyyapaşa Chest Diseases and Thoracic Surgery Teaching and Research Hospital.

14

Page 15: 1 The management of adverse effects in tuberculosis treatment Dr. Özlen Tümer Süreyyapaşa Chest Diseases and Thoracic Surgery Teaching and Research Hospital.

15

Pyrazinamide (Z)• Analog of nicotinamide.• The active derivate of Z is pyrazinoic acid.It is

bactericidal against intracellularly growing bacteria.

• It is an important drug for the initial phase of treatment because of its sterilizing effect.

• It has a good penetration into all body fluids. It is inactivated in liver and excreted in urine.

Page 16: 1 The management of adverse effects in tuberculosis treatment Dr. Özlen Tümer Süreyyapaşa Chest Diseases and Thoracic Surgery Teaching and Research Hospital.

16

Side effects of Pyrazinamide• Hepatotoxicity• Hyperuricemia: As pyrazinoic acid inhibits uric

acid excretion, serum uric acid level is elevated in 40% of patients.

• Gout like Arthralgia: Accumulation of uric acid causes polyarthralgia.

• Others: Skin rash,vomiting, anemia, lupus, seizures,photodermatitis

Page 17: 1 The management of adverse effects in tuberculosis treatment Dr. Özlen Tümer Süreyyapaşa Chest Diseases and Thoracic Surgery Teaching and Research Hospital.

17

Ethambutol (E)

• E was discovered in 1961• It has a bacteriostatic effect. • It is taken orally, its absorption is rapid

and not effected by food. • It has poor penetration into the CSF.• It is eliminated by kidney. If there is renal

failure its serum concentrations must be followed up.

Page 18: 1 The management of adverse effects in tuberculosis treatment Dr. Özlen Tümer Süreyyapaşa Chest Diseases and Thoracic Surgery Teaching and Research Hospital.

18

Side effects of Ethambutol• Ocular toxicity• Aplastic anemia• Rash, • Lupus erythematosus, • Thrombocytopenia• Hyperuricemia

Page 19: 1 The management of adverse effects in tuberculosis treatment Dr. Özlen Tümer Süreyyapaşa Chest Diseases and Thoracic Surgery Teaching and Research Hospital.

19

Streptomycin (S)• Discovered by SA Waksman it is an

aminoglycoside used since 1946. • Its administration is intramuscular,occasionally

intravenous.• Dosage is reduced in elderly.• S has a limited ability to penetrate membranes

and cell walls, but it still penetrates into CSF in case of meningitis.

• It inhibates the protein synthesis of bacilli.

Page 20: 1 The management of adverse effects in tuberculosis treatment Dr. Özlen Tümer Süreyyapaşa Chest Diseases and Thoracic Surgery Teaching and Research Hospital.

20

Side effects of Streptomycin

• Ototoxicity: Vertigo,ataxia, hearing loss

Ototoxic to fetus

• Nephrotoxicity

• Electrolyte abnormalities

• Fever and rash

• Hypersensitivity reactions, anaphylaxia

Page 21: 1 The management of adverse effects in tuberculosis treatment Dr. Özlen Tümer Süreyyapaşa Chest Diseases and Thoracic Surgery Teaching and Research Hospital.

21

Second line drugsSecond line drugsAmikacin,kanamycin 15 mg/kg

Capreomycin 15 mg/kg

Ofloxacin 600-800 mg

Levofloxacin 500-750 mg

Moxifloxacin 400 mg

Ethionamide/Prothionamide 500-750 mg

Cycloserine/Terizidon 500-750 mg

Page 22: 1 The management of adverse effects in tuberculosis treatment Dr. Özlen Tümer Süreyyapaşa Chest Diseases and Thoracic Surgery Teaching and Research Hospital.

22

Second line drugs (2)Second line drugs (2)

PAS 8-12 gr

Clofazimine 100-300 mg

Amoxicillin+Clavulanate 2 gr

Clarithromycin 1000 mg

Rifapentin 600mg/2 x wk

Rifabutin 300 mg

Linezolid (Zyvox) 600mg

Page 23: 1 The management of adverse effects in tuberculosis treatment Dr. Özlen Tümer Süreyyapaşa Chest Diseases and Thoracic Surgery Teaching and Research Hospital.

23

Side effects of second line drugsSide effects of second line drugs

GI upset (PAS,ETH)Hearing loss (KM,AMK)Psychotic reaction-depression (CS)

Seizures (CS)

Hepatotoxicity (ETH,PAS)

Arthralgia (Quinolones)

Peripheral neuropathy (CS)

Hypothyroidism (PAS,ETH)

Discoloration of skin (Clofazimine)

Electrolyte abnormalities (CM,AMK,KM)

Page 24: 1 The management of adverse effects in tuberculosis treatment Dr. Özlen Tümer Süreyyapaşa Chest Diseases and Thoracic Surgery Teaching and Research Hospital.

24

Characteristics of drugs used in TB treatment

The side-effects of TB drugsManagement of minor adverse effectsManagement of major adverse effectsDrug interactions

Page 25: 1 The management of adverse effects in tuberculosis treatment Dr. Özlen Tümer Süreyyapaşa Chest Diseases and Thoracic Surgery Teaching and Research Hospital.

25

Minor Side EffectsMinor Side Effects

• Loss of appetite, vomiting, abdominal pain

• Arthralgia

• Burning of the feet

• Fever

• Discoloration of urine, tears etc.

• Itching

Page 26: 1 The management of adverse effects in tuberculosis treatment Dr. Özlen Tümer Süreyyapaşa Chest Diseases and Thoracic Surgery Teaching and Research Hospital.

26

Nausea, vomiting, gastrointestinal distress

• Administration time can be changed, dosages can be divided, some agents can be given with food.

Antacids (2 hours before or after the drug intake)

Anti-emetics

H2blockers-proton pump inhibitors• Responsible agent is stopped.

• Responsible agent can be withdrawn.

Page 27: 1 The management of adverse effects in tuberculosis treatment Dr. Özlen Tümer Süreyyapaşa Chest Diseases and Thoracic Surgery Teaching and Research Hospital.

27

Arthralgia• PZA• Quinolones NSAI drugs,exercise

Peripheral neuropathyParasthesia, burning sensation on the extremities are

typical. • INH• Aminoglycosides • Cycloserine • Quinolones

•Drug can be stopped. Peripheral neuropathy is treated with Pyridoxine (100-200 mg/daily) . •exercise

Page 28: 1 The management of adverse effects in tuberculosis treatment Dr. Özlen Tümer Süreyyapaşa Chest Diseases and Thoracic Surgery Teaching and Research Hospital.

28

Fever• Fever is drug related if it resolves within

24 hours after stopping all drugs. Agents should be started one by one.

Itching• Symptomatic treatment with

antihistaminesOrange/red urine• Patients should be told that this is normal.

Page 29: 1 The management of adverse effects in tuberculosis treatment Dr. Özlen Tümer Süreyyapaşa Chest Diseases and Thoracic Surgery Teaching and Research Hospital.

29

Characteristics of drugs used in TB treatment

The side-effects of TB drugsManagement of minor adverse effectsManagement of major adverse effectsDrug interactions

Page 30: 1 The management of adverse effects in tuberculosis treatment Dr. Özlen Tümer Süreyyapaşa Chest Diseases and Thoracic Surgery Teaching and Research Hospital.

30

Major side effectsMajor side effects

• Hepatotoxicity• Cutaneous reactions• Hearing loss,dizziness• Optic neurotoxicity • Acute renal failure • Thrombocytopenic purpura • Hemolytic anemia • Hypersensitivity reactions-Anaphylaxia• Psychotic reactions• Lupus like syndrome-pleural effusion

Page 31: 1 The management of adverse effects in tuberculosis treatment Dr. Özlen Tümer Süreyyapaşa Chest Diseases and Thoracic Surgery Teaching and Research Hospital.

31

Hepatotoxicity(Drug induced hepatitis)

• INH,RIF, PZA• Ethionamid,Quinolones,PAS• Patient should be hospitalized. Drugs are

discontinued, if liver enzymes(ALT,AST) are 5 fold higher or the patient has symptoms. Drugs are restarted when ALT,AST return to normal.

• If hepatitis re-occur the drugs are reintroduced gradually one by one. (HRZ) or (RHZ)

Page 32: 1 The management of adverse effects in tuberculosis treatment Dr. Özlen Tümer Süreyyapaşa Chest Diseases and Thoracic Surgery Teaching and Research Hospital.

32

Cutaneous reactions

• Itching and minor rash are frequent. Antihistamine can be used

• In case of generalized erythematous rash all drugs should be stopped.when rash is improved drugs can be started one bt one, at intervals of 2-3 days. (RIF should be started first).If no rash appears after the fist 3 drugs the fourth drug shoud not be started.

• Hypersensitivity reactions are rare: S, PAS, TH• Exfoliative dermatitis • Stevens-Johnson Syndrome: Toxic dermal necrosis of skin and mucosal membranes

Page 33: 1 The management of adverse effects in tuberculosis treatment Dr. Özlen Tümer Süreyyapaşa Chest Diseases and Thoracic Surgery Teaching and Research Hospital.

33

Page 34: 1 The management of adverse effects in tuberculosis treatment Dr. Özlen Tümer Süreyyapaşa Chest Diseases and Thoracic Surgery Teaching and Research Hospital.

34

Page 35: 1 The management of adverse effects in tuberculosis treatment Dr. Özlen Tümer Süreyyapaşa Chest Diseases and Thoracic Surgery Teaching and Research Hospital.

35

Page 36: 1 The management of adverse effects in tuberculosis treatment Dr. Özlen Tümer Süreyyapaşa Chest Diseases and Thoracic Surgery Teaching and Research Hospital.

36

Hearing loss

• Aminoglycosides

Capreomycin is less toxic

• It is recommended to obtain audiometry at the initiation of therapy.

• Dosage can be reduced or drug can be stopped.

Page 37: 1 The management of adverse effects in tuberculosis treatment Dr. Özlen Tümer Süreyyapaşa Chest Diseases and Thoracic Surgery Teaching and Research Hospital.

37

Retrobulbar neuritis

• usually with high dosages.Reduced visual acuity, central scotoma, loss of ability to see green and red.

• E is stopped and withdrawn from treatment. Usually reversible.

Page 38: 1 The management of adverse effects in tuberculosis treatment Dr. Özlen Tümer Süreyyapaşa Chest Diseases and Thoracic Surgery Teaching and Research Hospital.

38

Hipersensitivity reactions

• Hemolytic anemia,

• Thrombocytopenic purpura,

• Shock,

• Acute renal failure

All drugs should be stopped.Rifampin is usually responsible.Treatment is restarted without R when the signes diminish.

Page 39: 1 The management of adverse effects in tuberculosis treatment Dr. Özlen Tümer Süreyyapaşa Chest Diseases and Thoracic Surgery Teaching and Research Hospital.

39

Psychotic symptoms

• INH

• cycloserine

• quinolones

Initiate antipsychotic drugs

Piridoxin 300 mg

• Patient is under observation

• Dosage reduced or drug stopped

Page 40: 1 The management of adverse effects in tuberculosis treatment Dr. Özlen Tümer Süreyyapaşa Chest Diseases and Thoracic Surgery Teaching and Research Hospital.

40

pleural effusion–paradoxical response

• Formation of pleural effusion during a successful treatment is called a paradoxical response.

• Elevated level of ANA and decreased level of total complement in pleural fluid analysis reveal lupus like syndrome.This could be with or without systemic SLE. Isoniazid might be discontinued.

Page 41: 1 The management of adverse effects in tuberculosis treatment Dr. Özlen Tümer Süreyyapaşa Chest Diseases and Thoracic Surgery Teaching and Research Hospital.

41

Drug withdrawn Recommended regimen

Initial phase continuation phase

H R+Z+E (2 mo) R+E (7 mo)

Z H+R+E (2 mo) H+R (7 mo)

E H+R+Z (2 mo) H+R (4 mo)

R H+Z+E (2 mo) H+E (16 mo)

R+Z H+E+S (2 mo) H+E (16 mo)

H+R+Z E+S+Mox(2 mo)

E+ Mox (22 mo)

Page 42: 1 The management of adverse effects in tuberculosis treatment Dr. Özlen Tümer Süreyyapaşa Chest Diseases and Thoracic Surgery Teaching and Research Hospital.

42

Monitoring of side effects

• Asking for visual complaints

• Asking for hearing complaints

• Asking for drug-food allergies

• Asking for additional diseases

• Liver enzymes

• Hemogram

Page 43: 1 The management of adverse effects in tuberculosis treatment Dr. Özlen Tümer Süreyyapaşa Chest Diseases and Thoracic Surgery Teaching and Research Hospital.

43

Characteristics of drugs used in TB treatment

The side-effects of TB drugsManagement of minor adverse effectsManagement of major adverse effectsDrug interactions

Page 44: 1 The management of adverse effects in tuberculosis treatment Dr. Özlen Tümer Süreyyapaşa Chest Diseases and Thoracic Surgery Teaching and Research Hospital.

44

ISONIAZID

• Phenytoin

• Carbamazepine

• Warfarin

• Diazepam

• Theophylline

• Prednisolone

• Ketoconazole

İncreases serum concentration

Effects of H opposed

Page 45: 1 The management of adverse effects in tuberculosis treatment Dr. Özlen Tümer Süreyyapaşa Chest Diseases and Thoracic Surgery Teaching and Research Hospital.

45

INH

• PAS

• Insulin

• Carbamazepine

• Theophylline

• Acetominophen hepatotoxicity is increased by INH.

Effects of INH potentiated

Page 46: 1 The management of adverse effects in tuberculosis treatment Dr. Özlen Tümer Süreyyapaşa Chest Diseases and Thoracic Surgery Teaching and Research Hospital.

46

RIFAMPICIN induces several enzymes in the cytochrome P-450 system

• Oral anti-coagulants• Oral contraceptives• Oral antidiabetics• Corticosteroids• Digoxin• Verapamil• Insulin• Antifungals,chloramphenicol• Theophylline• Protease inhibitors • Other anti-viral agents

Reduces serum concentrations

Page 47: 1 The management of adverse effects in tuberculosis treatment Dr. Özlen Tümer Süreyyapaşa Chest Diseases and Thoracic Surgery Teaching and Research Hospital.

47

RIF

• Cotrimoxazole potentiates the effect

of RIF .

• Ketoconazole reduces resorption of

RIF and can cause treatment failure.

Page 48: 1 The management of adverse effects in tuberculosis treatment Dr. Özlen Tümer Süreyyapaşa Chest Diseases and Thoracic Surgery Teaching and Research Hospital.

48

Pyrazinamide

• Allopurinol increases plasma level of pyrazinoic acid.Therefore it is not used for Z-induced arthralgias.

Ethambutol

• Aluminium-Magnesium antacid reduces E resorption.

Streptomycin

• Ototoxicity is increased by diuretics such as furosemide.

Page 49: 1 The management of adverse effects in tuberculosis treatment Dr. Özlen Tümer Süreyyapaşa Chest Diseases and Thoracic Surgery Teaching and Research Hospital.

49

Thanks…

..


Recommended